Cargando…
Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533513/ https://www.ncbi.nlm.nih.gov/pubmed/36199067 http://dx.doi.org/10.1186/s13063-022-06814-8 |
| _version_ | 1784802362650525696 |
|---|---|
| author | Abouhajar, Alaa Alcock, Lisa Bigirumurame, Theophile Bradley, Penny Brown, Laura Campbell, Ian Del Din, Silvia Faitg, Julie Falkous, Gavin Gorman, Grainne S. Lakey, Rachel McFarland, Robert Newman, Jane Rochester, Lynn Ryan, Vicky Smith, Hesther Steel, Alison Stefanetti, Renae J. Su, Huizhong Taylor, Robert W. Thomas, Naomi J. P. Tuppen, Helen Vincent, Amy E. Warren, Charlotte Watson, Gillian |
| author_facet | Abouhajar, Alaa Alcock, Lisa Bigirumurame, Theophile Bradley, Penny Brown, Laura Campbell, Ian Del Din, Silvia Faitg, Julie Falkous, Gavin Gorman, Grainne S. Lakey, Rachel McFarland, Robert Newman, Jane Rochester, Lynn Ryan, Vicky Smith, Hesther Steel, Alison Stefanetti, Renae J. Su, Huizhong Taylor, Robert W. Thomas, Naomi J. P. Tuppen, Helen Vincent, Amy E. Warren, Charlotte Watson, Gillian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9533513 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95335132022-10-06 Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy Abouhajar, Alaa Alcock, Lisa Bigirumurame, Theophile Bradley, Penny Brown, Laura Campbell, Ian Del Din, Silvia Faitg, Julie Falkous, Gavin Gorman, Grainne S. Lakey, Rachel McFarland, Robert Newman, Jane Rochester, Lynn Ryan, Vicky Smith, Hesther Steel, Alison Stefanetti, Renae J. Su, Huizhong Taylor, Robert W. Thomas, Naomi J. P. Tuppen, Helen Vincent, Amy E. Warren, Charlotte Watson, Gillian Trials Correction BioMed Central 2022-10-05 /pmc/articles/PMC9533513/ /pubmed/36199067 http://dx.doi.org/10.1186/s13063-022-06814-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Abouhajar, Alaa Alcock, Lisa Bigirumurame, Theophile Bradley, Penny Brown, Laura Campbell, Ian Del Din, Silvia Faitg, Julie Falkous, Gavin Gorman, Grainne S. Lakey, Rachel McFarland, Robert Newman, Jane Rochester, Lynn Ryan, Vicky Smith, Hesther Steel, Alison Stefanetti, Renae J. Su, Huizhong Taylor, Robert W. Thomas, Naomi J. P. Tuppen, Helen Vincent, Amy E. Warren, Charlotte Watson, Gillian Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy |
| title | Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy |
| title_full | Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy |
| title_fullStr | Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy |
| title_full_unstemmed | Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy |
| title_short | Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy |
| title_sort | correction: acipimox in mitochondrial myopathy (aimm): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533513/ https://www.ncbi.nlm.nih.gov/pubmed/36199067 http://dx.doi.org/10.1186/s13063-022-06814-8 |
| work_keys_str_mv | AT correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT abouhajaralaa correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT alcocklisa correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT bigirumurametheophile correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT bradleypenny correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT brownlaura correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT campbellian correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT deldinsilvia correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT faitgjulie correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT falkousgavin correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT gormangrainnes correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT lakeyrachel correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT mcfarlandrobert correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT newmanjane correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT rochesterlynn correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT ryanvicky correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT smithhesther correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT steelalison correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT stefanettirenaej correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT suhuizhong correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT taylorrobertw correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT thomasnaomijp correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT tuppenhelen correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT vincentamye correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT warrencharlotte correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy AT watsongillian correctionacipimoxinmitochondrialmyopathyaimmstudyprotocolforarandomiseddoubleblindedplacebocontrolledadaptivedesigntrialoftheefficacyofacipimoxinadultpatientswithmitochondrialmyopathy |